bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2019: S A J J M A M F J
2018: D N O S

 
  Other news for:
Fatigue
Headache
Sleep Disorders
Sports Medicine
 Resources from HONselect
Half-Dose of Mountain Sickness Med Works as Well as Full Dose

By Robert Preidt

THURSDAY, March 14, 2019 (HealthDay News) -- A lower dose of a medication to prevent acute mountain sickness is as effective as the standard, higher dose, a new study finds.

Acute mountain sickness (AMS) can cause headaches, gastrointestinal upset, fatigue, weakness, vertigo and sleep problems.

Many hikers and climbers use a drug called acetazolamide (Diamox) to prevent AMS. The standard adult dose is 125 milligrams (mg) twice a day. But the medication can cause side effects, especially at high doses, including altered sensation of taste, frequent urination, headache, nausea and rash.

Researchers wanted to find the lowest possible dose to prevent acute mountain sickness with the fewest and least severe side effects.

In the study, 73 participants took twice-daily doses of either 125 mg or 62.5 mg of acetazolamide while still at low altitudes.

Those who took the lower dose were no more likely to develop AMS than those who took the standard dose, according to the study published in the March issue of the journal Wilderness & Environmental Medicine.

"We found that half the recommended prophylactic dose, 62.5 mg twice daily, was just as effective in preventing AMS," lead investigator Dr. Scott McIntosh said in a journal news release.

McIntosh is a faculty member in the Division of Emergency Medicine at the University of Utah in Salt Lake City.

"The [prevention] of altitude illness with the lowest effective dose of acetazolamide has been a topic of discussion in mountain medicine for many years. While high-altitude mountaineers have reported using lower doses with beneficial effects, to our knowledge, this is the first formal study to test a dose lower than twice-daily 125 mg," McIntosh said.

Up to a quarter of trekkers and climbers who venture above 8,200 feet experience acute mountain sickness. That rate rises to between 50 percent and 85 percent of people who ascend between 14,760 and 18,040 feet.

A gradual increase in altitude can help prevent AMS. When that's not possible, acetazolamide is the standard medication to prevent altitude illness.

More information

The U.S. National Library of Medicine has more on acute mountain sickness.

SOURCE: Wilderness & Environmental Medicine, news release, March 11, 2019

Copyright © 2019 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=743716

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Headache
Sleep
Research Personnel
Fatigue
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact